Skip to main content
. 2018 Jun 8;1(2):e180243. doi: 10.1001/jamanetworkopen.2018.0243

Table 1. Characteristics of Patients With Acute Respiratory Infections in the 2013-2014 and 2014-2015 Influenza Seasons at Ambulatory Care Settings Affiliated With the US Influenza Vaccine Effectiveness Networka.

Characteristic Patients, No. (%)
Total (N = 14 987)b Prescribed Antibiotic (n = 6136)c
Sex
Male 6349 (42) 2567 (40)
Female 8638 (58) 3569 (41)
Age group, y
0.5-2 918 (6) 398 (43)
2 to <5 1488 (10) 589 (40)
5 to <18 3294 (22) 1186 (36)
18 to <50 4948 (33) 1938 (39)
50 to <65 2563 (17) 1183 (46)
≥65 1776 (12) 842 (47)
Race
White 11 892 (80) 5150 (43)
Black 1407 (9) 424 (30)
Other 1619 (11) 534 (33)
Study site
A 4286 (29) 1353 (32)
B 3112 (21) 1629 (52)
C 2699 (18) 1166 (43)
D 2315 (15) 858 (37)
E 2575 (17) 1130 (44)
Time from symptom onset to presentation for care, d
≤2 4678 (31) 1610 (34)
3-4 5719 (38) 2406 (42)
5-7 4590 (31) 2120 (46)
≥1 Chronic medical condition 5331 (36) 2315 (43)
Laboratory-confirmed influenzad 3381 (22) 1017 (30)
a

Acute respiratory infection is defined by cough with 7 days’ duration or less.

b

Percentage indicates the percentage in the column.

c

Percentage indicates the percentage in the row.

d

Tested by real-time reverse transcriptase–polymerase chain reaction in all enrolled patients. Testing was performed for research purposes. Clinicians were unaware of results, except for 1 site at which clinicians were notified of positive real-time reverse transcriptase–polymerase chain reaction research results within 48 hours of enrollment.